Skip to content

Clinical verification of neuromuscular transmission foot applicability

Clinical verification of neuromuscular transmission foot applicability

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019651
Enrollment
Unknown
Registered
2018-11-20
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular transmission of the foot

Interventions

Foot (stimulation: posterior tibial nerve, measurement: short flexor hallucis):7/5000 Cìji jìng hòu shénjing Stimulating posterior tibial nerve
Hand (stimulation: ulnar nerve, measurement: thumb adductor):Stimulating ulnar nerve

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients agrees and signs an informed consent form; 2. Patients should undergo general anesthesia surgery and use muscle relaxants. The limbs are exposed and fixed in vitro, the skin is intact, and there is no inflammation or obvious damage; 3. ASAI ~ III, no serious heart, lung, liver, kidney dysfunction;. 4. Aged 3 to 65 years old, BMI 16 ~ 28kg / m2, regardless of gender; 5. Previously no myasthenia gravis affects diseases such as muscle nerve junction transmission.

Exclusion criteria

Exclusion criteria: 1. nerve injury or other neuromuscular diseases, preoperative application of drugs that affect neuromuscular conduction and patients with severe liver and kidney disease; 2. patients with inflammation or obvious damage to the skin of the ulnar and sacral nerves; 3. a patient wearing an implantable cardiac pacemaker; 4. Body mass index > 28kg/m2; 5. Coronary heart disease and neostigmine contraindications; 6. need to retain the tracheal catheter after surgery to return to the intensive care unit to continue treatment; 7. Patients considered by other clinicians to be unsuitable for clinical trials

Design outcomes

Primary

MeasureTime frame
TOFR;

Countries

China

Contacts

Public ContactLi Shangrong

The Third Affiliated Hospital of Zhongshan University

13926006350@163.com+86 13926006350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026